Gotowa bibliografia na temat „Gray platelet syndrome”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Gray platelet syndrome”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Gray platelet syndrome"
Wills, E. J. "Gray Platelet Syndrome". Ultrastructural Pathology 13, nr 4 (styczeń 1989): 451–55. http://dx.doi.org/10.3109/01913128909048495.
Pełny tekst źródłaMichelson, Alan D. "Gray platelet syndrome". Blood 121, nr 2 (10.01.2013): 250. http://dx.doi.org/10.1182/blood-2012-09-455550.
Pełny tekst źródłaBain, Barbara J., i Manju Bhavnani. "Gray platelet syndrome". American Journal of Hematology 86, nr 12 (28.07.2011): 1027. http://dx.doi.org/10.1002/ajh.22055.
Pełny tekst źródłaRosa, Jean-Philippe. "The gray platelet syndrome". Sang thrombose vaisseaux 26, nr 5 (wrzesień 2014): 240–54. http://dx.doi.org/10.1684/stv.2014.0854.
Pełny tekst źródłaRosa, Jean-Philippe. "The gray platelet syndrome". Hématologie 19, nr 2 (marzec 2013): 123–35. http://dx.doi.org/10.1684/hma.2013.0793.
Pełny tekst źródłaBaruch, Dominique, Theo Lindhout, Evelyne Dupuy i Jacques P. Caen. "Thrombin-Induced Platelet Factor Va Formation in Patients with a Gray Platelet Syndrome". Thrombosis and Haemostasis 58, nr 02 (1987): 768–71. http://dx.doi.org/10.1055/s-0038-1645967.
Pełny tekst źródłaTubman, Venée N., Jason E. Levine, Dean R. Campagna, Rita Monahan-Earley, Ann M. Dvorak, Ellis J. Neufeld i Mark D. Fleming. "X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation". Blood 109, nr 8 (5.01.2007): 3297–99. http://dx.doi.org/10.1182/blood-2006-02-004101.
Pełny tekst źródłaKöhler, Michael. "Treatment of Gray Platelet Syndrome". Thrombosis and Haemostasis 60, nr 01 (1988): 123. http://dx.doi.org/10.1055/s-0038-1647649.
Pełny tekst źródłaNurden, Paquita, Martine Jandrot-Perrus, Robert Combrié, Joelle Winckler, Veronique Arocas, Christelle Lecut, Jean-Max Pasquet, Thomas J. Kunicki i Alan T. Nurden. "Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome". Blood 104, nr 1 (1.07.2004): 107–14. http://dx.doi.org/10.1182/blood-2003-11-3842.
Pełny tekst źródłaRao, A. Koneti, i Deepak A. Rao. "Gray platelet syndrome: immunity goes awry". Blood 136, nr 17 (22.10.2020): 1898–900. http://dx.doi.org/10.1182/blood.2020008196.
Pełny tekst źródłaRozprawy doktorskie na temat "Gray platelet syndrome"
Delage, Laure. "Des déficiences génétiques comme modèles naturels pour l'étude de la régulation des checkpoints immunitaires et la caractérisation des réponses auto-immunes". Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5190.
Pełny tekst źródłaRecessive NBEAL2 mutations have been reported in patients with Gray Platelet Syndrome (GPS). This syndrome is characterized by a macro-thrombocytopenia, with platelets lacking alpha-granules, leading to bleeding disorders, often associated with splenomegaly. Thus, NBEAL2 plays a crucial role in the trafficking of alpha-granules in platelets. Moreover, our lab has also described NBEAL2 deficiencies in patients presenting clinical features of the autoimmune lymphoproliferative syndrome, suggesting a role of NBEAL2 in immune homeostasis and tolerance. A broader international cohort of GPS patients has been described, revealing immune system abnormalities (autoimmune diseases, autoantibodies, lymphopenia). If the role of NBEAL2 in the traffic of granules is often investigated, the exact mechanism leading to the development of autoimmune manifestations in GPS patients remains unknown. NBEAL2 belongs to a protein family involved in vesicular trafficking, all of which possess a conserved BEACH domain. Within this BEACH-domain containing proteins family, one of the closest members to NBEAL2 is LRBA. LRBA is involved in the recycling of CTLA-4, an inhibitory immune checkpoint. CTLA-4 plays a crucial role in the regulation of immune responses and tolerance. Recessive mutations of LRBA lead to similar clinical features as partial CTLA-4 deficiency: autoimmunity, lymphocytic infiltrations, and progressive B lymphopenia. Physiologically, LRBA prevents the lysosomal degradation of CTLA-4 and allows its recycling to the membrane. By analogy with LRBA, we investigated the importance of NBEAL2 in immune checkpoints intracellular trafficking and we brought new insights on its role in lymphocytes. Thus, NBEAL2 is a scaffold protein, binding LRBA, and involved in CTLA-4 trafficking as well as in vesicular trafficking in general. This work brings new knowledge to the regulation of CTLA-4 in activated T lymphocytes, a list of new partners for NBEAL2 protein and a new model of vesicular trafficking in which NBEAL2 is involved. Finally, a better understanding of the mechanisms leading to autoimmunity in patients with gray platelets syndrome could lead to better diagnosis and treatment management
Części książek na temat "Gray platelet syndrome"
Timson, David J., Richard J. Reece, James B. Thoden, Hazel M. Holden, Andrea L. Utz, Beverly M. K. Biller, Eugen-Matthias Strehle i in. "Gray Platelet Syndrome". W Encyclopedia of Molecular Mechanisms of Disease, 758–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_735.
Pełny tekst źródłaShahraki, Hojat, Akbar Dorgalaleh i Barbara J. Bain. "Gray Platelet Syndrome (GPS)". W Congenital Bleeding Disorders, 379–96. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76723-9_16.
Pełny tekst źródłaKianinodeh, Fatemeh, Maryam Sadat Hosseini i Barbara J. Bain. "Gray Platelet Syndrome: Diagnosis and Management". W Congenital Bleeding Disorders, 445–63. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-43156-2_17.
Pełny tekst źródłaVagts, Dierk A., Heike Kaltofen, Uta Emmig i Peter Biro. "Grey-Platelet-Syndrom (UK)/Gray-Platelet-Syndrom (USA)". W Anästhesie bei seltenen Erkrankungen, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-44368-2_108-1.
Pełny tekst źródłaKöhler, M. "Grey-platelet-Syndrom: Pathophysiologie, Klinik, Diagnostik und Therapie". W Hämostaseologie, 67–71. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-07673-6_9.
Pełny tekst źródła"Gray Platelet Syndrome". W Diagnostic Pathology: Blood and Bone Marrow, 322–25. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-323-39254-9.50068-4.
Pełny tekst źródłaPozdnyakova, Olga. "Gray Platelet Syndrome". W Hematopathology, 37–38. Elsevier, 2013. http://dx.doi.org/10.1016/b978-1-4377-1758-7.00016-6.
Pełny tekst źródłaStreszczenia konferencji na temat "Gray platelet syndrome"
Levy-Toledano, S., J. Enouf, M. Lebret, R. Bredoux i J. P. Caen. "ABNORMAL CALCIUM TRANSPORT INTO MICROSOMES OF GRAY PLATELET SYNDROME". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644747.
Pełny tekst źródłaMori, K., S. Suzuki, K. Sugai, Y. Akutsu, M. Ishikawa, H. Sakai i K. Hiwatashi. "INTRACELLULAR CA++ MOBILIZATION IN GRAY PLATELET SYNDROME. ELECTRONMICROSCOPIC STUDIES ON AEQUORIN LOADED PLATELETS". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644558.
Pełny tekst źródłaFACON, T., J. GOUPEMAND, C. CARON, M. ZANDECKI, M. H. ESTIENNE i A. COSSON. "GRAY PLATELET SYNDROME AND IDIOPATHIC PULMONARY FIBROSIS OCCURRING IN THE SAME PATIENT : A FORTUITOUS ASSOCIATION?" W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644559.
Pełny tekst źródłaLegrand, C., V. Dubernard, N. Kieffer i A. T. Nurden. "USE OF A MONOCLONAL ANTIBODY TO MEASURE THE SURFACE EXPRESSION OF THROMBOSPONDIN FOLLOWING PLATELET ACTIVATION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643821.
Pełny tekst źródłaPatscheke, H., i G. Mathieu. "MONITORING OF THE PLATELET ALPHA-GRANULE SECRETION IN THE AGGREGOMETER." W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643492.
Pełny tekst źródłaForestier, F., F. Daffos, C. Kaplan i P. Champeix. "PRENATAL DIAGNOSIS OF HEMORRHAGIC DISORDERS". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644270.
Pełny tekst źródłaWautier, J. L., Y. Gruel, B. Boizard, J. P. Caen, F. Daffos i F. Forestier. "ANTENATAL DIAGNOSIS OF THROMBOPATHY". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644271.
Pełny tekst źródłaCockbill, S. R., S. Heptinstall i H. B. Burmester. "A PLASMA FACTOR FROM A PATIENT WITH A BLEEDING TENDENCY CAUSES PLATELET SECRETION IN THE ABSENCE OF EXTRACELLULAR CALCIUM". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643489.
Pełny tekst źródłaRendu, F., T. Hovig, P. Marche, M. Lebret, D. Tenza, J. Maclouf, J. P. Caen i S. Levy-Toledano. "MEMBRANE SIGNAL TRANSDUCTION IN PLATELETS WITH ALTERED RELEASE REACTION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644746.
Pełny tekst źródła